UK Turns to Technology-Centric Strategy to Meet Pathology Challenges
By examining the UK’s technology-centric strategy and response, nations can right-size the practice of pathology and prepare for the future.
Read MorePosted by Chris Wolski | Jan 12, 2024 | Digital Pathology |
By examining the UK’s technology-centric strategy and response, nations can right-size the practice of pathology and prepare for the future.
Read MorePosted by Andy Lundin | Jan 9, 2024 | Cancer, Research |
PanGIA Biotech is preparing to launch new clinical studies in multi-cancer early detection using the PanGIA Liquid Biopsy Platform.
Read MorePosted by Andy Lundin | Jan 9, 2024 | Diagnostic Technologies |
Picodya, the creator of a hybrid IVD solution for multiplexed POC testing, announced the deployment of its B-Matrix technology in NIH labs.
Read MorePosted by Andy Lundin | Jan 8, 2024 | Lung Cancer |
ChromaCode will collaborate with Tennessee Oncology to test the performance of ChromaCode’s HDPCR NSCLC biomarker assay.
Read MorePosted by Andy Lundin | Jan 8, 2024 | Diabetes & Metabolic Diseases, Womens Health |
The clearance makes it possible for women who live with diabetes to receive monitoring of A1c, using laboratory tests performed on the Q-Pad.
Read More